Summary Keywords GLP-1, Alzheimers disease, Parkinsons disease, neuroinflammation, amyloid beta, mitochondrial dysfunction, brain glucose hypometabolism, insulin resistance Citation Reich N and Hlscher C (2022) The neuroprotective effects of glucagon-like peptide 1 in Alzheimers and Parkinsons disease: An in-depth review
Was sie taten: Eine zweiphasige Studie, zuerst in der Schale mit menschlichen Endothelzellen (HUVECs), dann in einer lebenden Ratte mit einer ischmischen Extremitt (= sie verschlossen die Arterie, sodass kein Blut zum Bein gelangte)
Not a drug, food, dietary supplement, cosmetic, or medical product
It's essential to discuss any allergies, health issues, or contraindications with the doctor during your consultation to guarantee your safety throughout the treatment process
What distinguishes BPC-157 from many other peptides is its origin story
Every "GLP-1 patch" sold online in 2026 is a dietary supplement sticker